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A B S T R A C T   
We evaluated a novel ‘protected’ biopsy method to reliably ascertain the spatial distribution of the mucosa- 
adherent colonic microbiota. Apart from minor differences at genus level, overall similarities along the colon 
were high between the various areas, irrespective of protected or unprotected sampling.   
An aberrant gut microbiota composition has been found to be 
implicated in various chronic and metabolic diseases, including in-
flammatory bowel disease (IBD) (Sokol et al., 2006; Ottman et al., 
2012). The gut microbiota plays a key role in inflammation and hence 
possibly also in the development of the mucosal lesions that are char-
acteristic of IBD. Characterization of the gut microbial ecological pat-
terns may be essential to the understanding of the pathophysiology of 
inflammation in IBD. In current IBD research, gut microbiota profiling is 
performed on fecal samples (Kolho et al., 2015; Norman et al., 2015), 
samples of the mucus layer (Johansson et al., 2014), and colonoscopic 
biopsy samples (Rossen et al., 2015). Several sampling methods have 
been described, but currently there is no validated method for accurate 
and systematic collection and processing of samples (Zhang et al., 2017). 
Various studies have reported differences in luminal and mucosal 
microbiota profiles along the intestines of healthy subjects and IBD 
patients (Lavelle et al., 2013; Lavelle et al., 2015; Donaldson et al., 
2016). Controversy exists concerning the spatial variation of the mi-
crobial communities along the length of the colonic mucosa, however. 
Whereas some studies report no spatial differences along the colonic 
mucosa (Lavelle et al., 2013; Lavelle et al., 2015; Zoetendal et al., 2002; 
Eckburg et al., 2006; Hong et al., 2011), others have observed a 
biogeographical gradient of colonic mucosa-associated microbiota (De 
Cárcer et al., 2011; Zhang et al., 2014; Flynn et al., 2018). We hypoth-
esize that contamination of proximally collected intestinal samples with 
microbiota residing in distal colonic sites may partly explain these 
different observations. In this study, we evaluated a new sampling 
technique for characterization of the colonic microbiota profiles which 
allows for collection of ‘protected biopsies’, thereby preventing 
contamination of the working channel of the endoscope and subse-
quently the biopsy forceps with microbiota residing in distal colonic 
sites while being advanced through the working channel of the endo-
scope for sampling of more proximal colonic sites (Fig. 1). Aiming to 
move towards a better understanding of the microbial spatial distribu-
tion implicated in the pathophysiology of IBD, the primary objective in 
this study was to assess whether there are true differences in mucosa- 
adherent microbiota along different locations in the bowel in a patient 
group without active inflammatory disease. To this end, we hypothe-
sized that if there are true differences in microbial composition along the 
colon, we would find differences between the protected biopsies of the 
most proximal and the most distal sites that we would not find between 
the unprotected biopsies of these sites, due to the expected high risk of 
contamination of the working channel upon insertion of the endoscope. 
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Eleven patients scheduled for colonoscopy for diagnostic purposes 
were included in the study (five men and six women [age range 34–76 
years old, median 54]). The indications for colonoscopy included rectal 
bleeding, iron deficiency anemia, neoplasia surveillance and altered 
bowel pattern. Patients received bowel lavage with either Picoprep or 
Moviprep. Their median total Boston Bowel Preparation Scale (BBPS) 
score was 8 (range 3–9). Additional demographics and details of per-
formed colonoscopies are listed in Supplementary Table 1. Patients were 
sampled in the terminal ileum (TI), the ascending colon (CA), and the 
rectosigmoid (RS). At each location two samples were collected; one 
‘unprotected’ (U) mucosal biopsy following the routine biopsy proced-
ure, and one ‘protected’ (P) mucosal biopsy which was collected using a 
P biopsy device that was assembled as follows. Under sterile conditions, 
a standard 2.4 mm Captura biopsy forceps (Wilson-Cook Medical, 
Winston-Salem, NC, US) was premounted in a 3.7 mm HCP-C hemostasis 
delivery catheter (Wilson-Cook Medical, Winston-Salem, NC, US), and 
sealed off with a silicone cap. The premounted system was sterilized 
with ethylene oxide and packed in a sealed bag, which was subsequently 
exposed to UV-light in order to destroy any bacterial DNA. The extent to 
which the P biopsy method protects from contamination was examined 
by 16S rRNA gene qPCR analysis as described by Fuentes et al. (2017) on 
the presence of bacterial DNA that was collected on the biopsy forceps 
during advancement of a P and subsequently U biopsy device up until 5 
cm before the tip of a used endoscope channel right after colonoscopy 
with suboptimal bowel preparation (n = 4). The average bacterial DNA 
abundance of the U samples was 1.47*105 times higher than of the P 
samples, whereas of the P samples bacterial DNA abundance was 
3.22*103 times higher than of the negative air control samples. No 
bacterial DNA was detected on devices that were not advanced. These 
results confirmed that the P biopsy method protects from 
contamination. 
Upon collection of the P mucosal biopsy, the catheter was advanced 
through the working channel of the endoscope, and the cap was pushed 
off by the forceps at the mucosal site of interest. Care was taken to select 
an area devoid of residual luminal feces. After collection of one biopsy, 
the biopsy forceps was retrieved through the catheter. The biopsy 
sample was immediately stored in liquid nitrogen. A new biopsy device 
was used for each mucosal biopsy sample. 
After thawing, specimens microbiota composition and diversity were 
determined using the Human Intestinal Tract Chip (HITChip) following 
the method previously described in other studies (Rajilic-Stojanovic 
et al., 2009; Lahti et al., 2011; Lahti et al., 2013), as well as through 
partial 16S rRNA (V1-V2) gene sequencing by Illumina MiSeq and 
analysis using SILVA v.132 and mothur MiSeq SOP v.1.42.3 (Kozich 
et al., 2013), as previously described by James et al. (2020). The 
HITChip platform is a phylogenetic microarray designed by Rajilic- 
Stojanovic et al. (2009) following a systematic probe design approach. 
Genus-like level data is generated following data organization according 
to specificity of probes for higher phylogenetic groups, which allows for 
analysis of differences between samples in terms of genus abundances. 
Statistical significance was calculated using a student’s t-test for the 
Pearson correlations on the 16S rRNA gene read data and the HITChip 
probe level data following the example set by Rajilic-Stojanovic et al. 
(2009), and a Wilcoxon rank sum test with Bonferroni-Holm correction 
for the genus-like level data, following the method previously carried 
out by Zoetendal et al. (2002). 
The results showed no significant differences in microbiota compo-
sition between P and U biopsies at HITChip probe level, nor did they 
show spatial differences between different (ileo)colonic sites (Fig. 2A). 
Comparisons of inter-site Pearson correlations of the samples confirmed 
that similarity between sites was not significantly different in P biopsies 
compared to U biopsies (Fig. 2B). 
Both analyses on HITChip probe signals and 16S rRNA sequence read 
showed that similarity between TI and CA and TI and RS was not 
significantly different between U and P biopsies. PCoA-analysis revealed 
no clear separation between P and U samples of TI, CA and RS (Fig. 3A). 
However, a significant difference was found between the P and U bi-
opsies of the CA and RS (Fig. 3B, p = 0.04). Correspondingly, neither the 
16S rRNA sequencing data nor the HITChip data showed significant 
taxonomic differences at genus-like level (data not shown) between P 
and U biopsies along the different colonic locations ( Supplementary 
Fig. S1). 
Although likely to be evenly spread throughout the intestines, a 
potentially microbiota-composition altering effect of bowel lavage must 
be taken into account with interpretation of the results (Harrell et al., 
2012; O’Brien et al., 2013) Unprepared mucosa may exhibit overall 
higher microbiota phylotype richness and diversity (O’Brien et al., 
2013). 
In summary, our data show high similarity in microbiota composi-
tion between the TI, the CA, as well as the RS, and thereby confirm 
findings from earlier studies (Lavelle et al., 2013; Lavelle et al., 2015; 
Zoetendal et al., 2002; Eckburg et al., 2006; Hong et al., 2011). We 
conclude that in individuals without colonic inflammation, no signifi-
cant spatial variation of the mucosa-associated microbiota profile along 
the colon exists. Hence, taking extra precautions by using a protected 
biopsies SOP such as ours may be warranted only when location-specific 
differences, such as inflammatory lesions versus normal adjacent mu-
cosa, are sought after. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.mimet.2021.106204. 
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